health

ABC Health

CNN Health

Fox News Health

iVillage

WSJ.com Health

  • In Drug Trial, Parents Weigh Life and Loss

    An experimental treatment could let children with a rare genetic disease live longer, but it may make them deaf.

  • Health-Law Foes Face Hurdle as Justices Weigh Subsidies

    Health-care law opponents face a challenge Wednesday in persuading the Supreme Court to strike down nationwide insurance subsidies: Doing so could put the law at odds with part of the court’s health-care decision three years ago.

  • Amgen Sees Positive Results From Kyprolis Study

    Amgen took a step forward in its efforts to make its Kyprolis cancer therapy a standard treatment for many multiple myeloma patients, saying the drug performed better than older rival Velcade in a study.

  • Big Insurer Tightens Hysterectomy Rules

    The nation’s largest health insurer, UnitedHealth, is imposing tighter controls on its coverage for hysterectomies after more than a year of debate over a medical device that was found to spread hidden cancer in some women undergoing the procedure.

  • Billion-Dollar Health Startups

    A Look at Proteus Digital and Moderna

  • Novartis Amends Heart-Drug Trial

    Novartis is amending a clinical trial of a promising heart drug it’s developing in order to address questions from doctors that the medication might contribute to an increased risk of Alzheimer’s disease.

  • More Than 1 Million People Pick New Health-Law Plans

    About 1.2 million people who bought coverage on HealthCare.gov in 2014 dropped their health plan and picked a new one through the site for 2015, the Obama administration said Wednesday.

  • Sanofi Wins Approval For New Insulin Drug

    Sanofi said it got a green light from U.S. regulators to sell its new insulin product Toujeo, a crucial launch for the French drug maker as it struggles to keep a firm grip on the all-important diabetes market.